These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36328268)

  • 1. Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review.
    Ismail A; El-Mahdy HA; Abulsoud AI; Sallam AM; Eldeib MG; Elsakka EGE; Zaki MB; Doghish AS
    Int J Biol Macromol; 2023 Jan; 224():1541-1565. PubMed ID: 36328268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers.
    El-Mahdy HA; Sallam AM; Ismail A; Elkhawaga SY; Elrebehy MA; Doghish AS
    Pathol Res Pract; 2022 May; 233():153886. PubMed ID: 35405621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways.
    Abdelmaksoud NM; El-Mahdy HA; Ismail A; Elsakka EGE; El-Husseiny AA; Khidr EG; Ali EM; Rashed MH; El-Demerdash FE; Doghish AS
    Pathol Res Pract; 2023 Apr; 244():154411. PubMed ID: 36921547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer.
    Fathi D; Elballal MS; Elesawy AE; Abulsoud AI; Elshafei A; Elsakka EGE; Ismail A; El-Mahdy HA; Elrebehy MA; Doghish AS
    Life Sci; 2023 Jun; 322():121667. PubMed ID: 37023952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs as potential game-changers in melanoma: A comprehensive review.
    Abd-Allah GM; Ismail A; El-Mahdy HA; Elsakka EGE; El-Husseiny AA; Abdelmaksoud NM; Salman A; Elkhawaga SY; Doghish AS
    Pathol Res Pract; 2023 Apr; 244():154424. PubMed ID: 36989843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis.
    Chen W; Zhou S; Mao L; Zhang H; Sun D; Zhang J; Li J; Tang JH
    Tumour Biol; 2016 Aug; 37(8):10011-9. PubMed ID: 27153853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of regulatory miRNAs of the PI3K/AKT signaling pathway in the pathogenesis of breast cancer.
    Rahmani F; Ferns GA; Talebian S; Nourbakhsh M; Avan A; Shahidsales S
    Gene; 2020 May; 737():144459. PubMed ID: 32045660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the biological role of miRNAs in prostate cancer suppression and progression.
    Doghish AS; Ismail A; El-Mahdy HA; Elkady MA; Elrebehy MA; Sallam AM
    Int J Biol Macromol; 2022 Feb; 197():141-156. PubMed ID: 34968539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways.
    Doghish AS; El-Mahdy HA; Ismail A; Hegazy M; Mokhtar MM; Elkhawaga SY; Elkady MA; Yehia AM; Elsakka EGE
    Pathol Res Pract; 2023 Mar; 243():154371. PubMed ID: 36791561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Regulatory Oncogenic or Tumor Suppressor miRNAs of PI3K/AKT Signaling Axis in the Pathogenesis of Colorectal Cancer.
    Soleimani A; Rahmani F; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
    Curr Pharm Des; 2018; 24(39):4605-4610. PubMed ID: 30636581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay - A review.
    El-Mahdy HA; Elsakka EGE; El-Husseiny AA; Ismail A; Yehia AM; Abdelmaksoud NM; Elshimy RAA; Noshy M; Doghish AS
    Pathol Res Pract; 2023 Feb; 242():154316. PubMed ID: 36682282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
    Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R
    Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
    Sun WM; Tao W; Li JC; Zhu DM; Miao Y
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
    Xu JH; Wang Y; Xu D
    Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNAs as potential markers for breast cancer and regulators of tumorigenesis and progression (Review).
    Mu H; Zhang W; Qiu Y; Tao T; Wu H; Chen Z; Xu G
    Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay - A review.
    Elrebehy MA; Al-Saeed S; Gamal S; El-Sayed A; Ahmed AA; Waheed O; Ismail A; El-Mahdy HA; Sallam AM; Doghish AS
    Int J Biol Macromol; 2022 Aug; 214():583-600. PubMed ID: 35768045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood-brain barrier and treatment strategies.
    Chhichholiya Y; Ruthuparna M; Velagaleti H; Munshi A
    Clin Transl Oncol; 2023 May; 25(5):1218-1241. PubMed ID: 36897508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers.
    Abadi AJ; Zarrabi A; Gholami MH; Mirzaei S; Hashemi F; Zabolian A; Entezari M; Hushmandi K; Ashrafizadeh M; Khan H; Kumar AP
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the Mediator Complex and MicroRNAs in Breast Cancer Etiology.
    Maldonado E; Morales-Pison S; Urbina F; Jara L; Solari A
    Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer.
    Ward A; Shukla K; Balwierz A; Soons Z; König R; Sahin O; Wiemann S
    J Pathol; 2014 Aug; 233(4):368-79. PubMed ID: 24752803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.